M. Nesbit
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 6
- Acute Myeloid Leukemia Research 5
- Genetics top 5%
-
- Sarcoma Diagnosis and Treatment 3
- Oncology top 10%
- Neutropenia and Cancer Infections 3
- Neurology top 5%
-
- Acute Lymphoblastic Leukemia research 8
-
- Virology and Viral Diseases 5
- Respiratory viral infections research 3
-
- Childhood Cancer Survivors' Quality of Life 5
M. Nesbit
36 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Hematology 467
- Genetics 225
- Pulmonary and Respiratory Medicine 665
- Oncology 431
- Neurology 231
Countries citing papers authored by M. Nesbit
This map shows the geographic impact of M. Nesbit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Nesbit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Nesbit more than expected).
Fields of papers citing papers by M. Nesbit
This network shows the impact of papers produced by M. Nesbit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Nesbit. The network helps show where M. Nesbit may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Nesbit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 15 | |
| 2 | 1994 | 1 | |
| 3 | 1994 | 57 | |
| 4 | 1993 | 52 | |
| 5 | Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.breakdown → | 1990 | 434 |
| 6 | 1990 | 65 | |
| 7 | 1989 | 74 | |
| 8 | 1989 | 1 | |
| 9 | 1988 | 7 | |
| 10 | 1988 | 36 | |
| 11 | 1987 | 31 | |
| 12 | 1985 | 71 | |
| 13 | Second malignant neoplasms in children: an update from the Late Effects Study Group.breakdown → | 1985 | 377 |
| 14 | Nursing care in childhood cancer: methadone. | 1982 | 8 |
| 15 | 聖域療法 未治療急性リンパ芽球白血病小児患者724名の無作為試験 小児がん研究グループ報告 | 1982 | 3 |
| 16 | 1978 | 38 | |
| 17 | Malignancy in children with and without genetically-determined immunodeficiencies. | 1978 | 4 |
| 18 | 1976 | 26 | |
| 19 | 1974 | 21 | |
| 20 | B-cell markers on lymphoblasts in acute lymphoblastic leukaemia. | 1974 | 45 |
About M. Nesbit
M. Nesbit is a scholar working on Hematology, Microbiology and Virology, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (8 papers), Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (5 papers), Virology and Viral Diseases (5 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Respiratory viral infections research (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hematology (467 citations), Genetics (225 citations) and Pulmonary and Respiratory Medicine (665 citations). M. Nesbit has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Meenhard Herlyn, Roger G. Evans, John M. Kissane, E. Gehan, Fred Askin, P. Thomas, Teresa J. Vietti, Ayten Cangır, E. Omer Burgert and Melvin Tefft. Their work appears in journals such as Journal of Clinical Oncology, Journal of General Virology, Virus Research, British Journal of Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.